About Vardhman Chemtech
Vardhman Chemtech is a company based in Chandigarh (India) founded in 1996 by Vivek Gupta and Suyog Jain. Vardhman Chemtech has raised $14 million across 1 funding round from investors including Piramal Group. The company has 98 employees as of October 31, 2024. Vardhman Chemtech operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Chandigarh, India
- Employees 98 as on 31 Oct, 2024
- Founders Vivek Gupta, Suyog Jain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$29.05 M (USD)1as on Mar 31, 2024
-
Net Profit
$1.23 M (USD)929as on Mar 31, 2024
-
EBITDA
$2.45 M (USD)108as on Mar 31, 2024
-
Total Equity Funding
$14 M (USD)
in 1 rounds
-
Latest Funding Round
$14 M (USD), Private Equity Round
Mar 06, 2012
- Investors
-
Employee Count
98
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vardhman Chemtech
Vardhman Chemtech has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $14 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vardhman Chemtech
Vardhman Chemtech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
Locked | Locked | Locked |
Investor details for Vardhman Chemtech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vardhman Chemtech
Investment portfolio details for Vardhman Chemtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vardhman Chemtech
Detailed financials for Vardhman Chemtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vardhman Chemtech Comparisons
Peer comparison for Vardhman Chemtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vardhman Chemtech
Vardhman Chemtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Vardhman Chemtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vardhman Chemtech
Complete news archive for Vardhman Chemtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vardhman Chemtech
Vardhman Chemtech was founded in 1996 and raised its 1st funding round 16 years after it was founded.
Vardhman Chemtech is headquartered in Chandigarh, India.
Vardhman Chemtech is a funded company, having raised a total of $14M across 1 funding round to date.
As of Oct 31, 2024, the latest employee count at Vardhman Chemtech is 98.
Annual revenue of Vardhman Chemtech is $29.05M as on Mar 31, 2024.
Vardhman Chemtech is an integrated manufacturer of bulk drugs, intermediates and fine chemicals in the Isoxazoles segment of penicillin. Currently, the company manufactures APIs and their variants, which it supplies to Indian drug-makers. The company also exports to key markets, such as the Far East, Indian sub-continent, SAARC countries, China, the Middle East, North Africa, East Africa, West Africa, Latin America and the Russian bloc. Their API facility is US FDA certified.
Vardhman Chemtech's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Vardhman Chemtech has 1 investor. Key investors include Piramal Group.